References
- IMS Institute for Healthcare Informatics. The global use of medicines: outlook through 2017. IMS Health Incorporated; Parsippany, NJ, USA: 2013
- Japanese Ministry of Health, Labour, and Welfare. Promotion of the use of generic drugs. Available from: www.mhlw.go.jp/english/policy_report/2012/09/120921.html [Last accessed 8 April 2014]
- Cantor LB. Ophthalmic generic drug approval process: implications for efficacy and safety. J Glaucoma 1997;6(5):344-9
- Roberts CW, Nelson PL. Comparative analysis of prednisolone acetate suspensions. J Ocul Pharmacol Ther 2007;23(2):182-7
- Chambers WA. Ophthalmic generics – are they really the same? Ophthalmology 2012;119(6):1095-6
- US FDA. Draft guidance on brinzolamide. Available from: www.fda.gov/downloads/Drugs/GuidanceComplianceRegulatoryInformation/Guidances/UCM384099.pdf [Last accessed 15 May 2014]
- US FDA. Draft guidance on cyclosporine. Available from: www.fda.gov/downloads/Drugs/GuidanceComplianceRegulatoryInformation/Guidances/UCM358114.pdf [Last accessed 15 May 2014]
- Novack GD. Quality of generic drugs. Ocul Surf 2013;11(1):54-6
- Kahook MY, Fechtner RD, Katz LJ, et al. A comparison of active ingredients and preservatives between brand name and generic topical glaucoma medications using liquid chromatography-tandem mass spectrometry. Curr Eye Res 2012;37(2):101-8
- Patel SC, Spaeth GL. Compliance in patients prescribed eyedrops for glaucoma. Ophthalmic Surg 1995;26(3):233-6
- Winfield AJ, Jessiman D, Williams A, Esakowitz L. A study of the causes of non-compliance by patients prescribed eyedrops. Br J Ophthalmol 1990;74(8):477-80
- Connor AJ, Severn PS. Force requirements in topical medicine use – the squeezability factor. Eye (Lond) 2011;25(4):466-9
- Narayanaswamy A, Neog A, Baskaran M, et al. A randmomized, crossover, open label pilot study to evaluate the efficacy and safety of Xalatan in comparison with generic Latanoprost (Latoprost) in subjects with primary open angle glaucoma or ocular hypertension. Indian J Ophthalmol 2007;55(2):127-31
- Egan P, Harris A, Siesky B, et al. Comparison of intraocular pressure in glaucoma subjects treated with Xalatan versus generic latanoprost. Acta Ophthalmol 2013. [Epub ahead of print]
- Susanna R Jr. Upredictability of glaucoma progression. Curr Med Res Opin 2009;25(9):2167-77
- Rotchford AP, King AJ. Repeatability of measurements of effectiveness of glaucoma medication. 2012;96(12):1494-7